Results 181 to 190 of about 99,309 (305)

Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study

open access: yesJournal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Advanced HIV disease (AHD) remains a leading cause of mortality in Latin America and the Caribbean (LAC), driven by late diagnosis, treatment gaps and structural barriers, particularly among key populations and children. Persistent disparities in healthcare access, stigma, and limited health system capacity highlight the need for ...
Evelina Chapman   +7 more
wiley   +1 more source

A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda

open access: yesJournal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Despite significant progress in HIV care globally, a persistent 30–40% of people present with advanced HIV disease with ≤200 CD4 cells/µl. The Visitect CD4 Advanced Disease platform is a point‐of‐care CD4 test being implemented in resource‐limited settings.
Elizabeth Nalintya   +18 more
wiley   +1 more source

Effect of Isoniazid Resistance on Treatment Outcome Among People With Pulmonary Tuberculosis in Korea. [PDF]

open access: yesJ Korean Med Sci
Lee JM   +20 more
europepmc   +1 more source

SIMULTANEOUS ANALYSIS OF ISONIAZID AND PYRIDOXINE HYDROCHLORIDE IN TABLETDOSAGE FORM USING PARTIAL LEAST SQUARES BASED ON INFRAREDSPECTRA PROFILE

open access: diamond
Lisda Rimayani Nasution   +5 more
openalex   +2 more sources

Sural/Radial Amplitude Ratio: A Useful Tool to Diagnose Non‐Length‐Dependent Neuropathy

open access: yesMuscle &Nerve, Volume 73, Issue 1, Page 34-40, January 2026.
ABSTRACT Introduction/Aims Patients with non‐length‐dependent neuropathy (NLDN) exhibit reduced sensory nerve action potential (SNAP) amplitudes in both lower and upper limbs. This study aimed to determine a threshold for the sural/radial amplitude ratio (SRAR) suggestive of NLDN.
Antoine Pegat   +6 more
wiley   +1 more source

Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV

open access: diamond
R. Borse   +8 more
openalex   +1 more source

Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo‐EM

open access: yesProtein Science, Volume 35, Issue 1, January 2026.
Abstract Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is responsible for a global health burden affecting over a quarter of the world's population. The increasing prevalence of drug‐resistant TB poses a significant threat to current treatment strategies.
Thomas Allport, Amanda K. Chaplin
wiley   +1 more source

Tuberculosis Masquerading as Behcet's Disease‐Pseudo Bechet's Syndrome: A Case‐Based Review of Literature

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
We report a case of recurrent oral/scrotal ulcers with systemic symptoms in a 33‐year‐old man masked pulmonary tuberculosis: imaging showed cavitary consolidations with effusion, and thoracoscopic pleural biopsy demonstrated acid‐fast bacilli. Anti‐tubercular therapy led to complete resolution, underscoring TB as a key Behçet's mimic to exclude before ...
Rinoosha Rachel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy